-
Moderna's rumored $50-plus price on COVID-19 vaccine draws ire as company touts
Moderna has yet to confirm its pricing plan for its phase 3 COVID-19 vaccine, but that hasn't stopped analysts and politicians from debating how it an...
2020-07-31 10:16 -
Who stole our eye health
"There is nothing more (frightening) than loss of sight, except loss of life." Recently, at this year's "National Eye Care Day" press conference, Wang...
2020-07-30 11:37 -
The pharmaceutical industry will undergo four major changes
In recent years, with the continuous expansion of volume procurement, it has also brought a major reshuffle to the pharmaceutical industry.
2020-07-29 11:06 -
The various unknown effects of lutein
The latest research results show that lutein has inhibitory effects on a variety of cancers, such as breast, prostate, rectal, colon, and skin cancers...
2020-07-28 17:08 -
Supply and demand status/development trend of China's heparin sodium industry
Heparin sodium is an anticoagulant (blood thinner) that prevents thrombosis. With the acceleration of the pace of life and the increase of population ...
2020-07-27 10:19 -
Pfizer, BioNTech snare $1.95B deal with U.S. government for COVID-19 vaccine
The Trump administration's Warp Speed initiative has placed its biggest bet yet on an accelerated COVID-19 vaccine—and Pfizer and BioNTech are the lu...
2020-07-24 14:05 -
Top 10 best-selling drugs announced in the first quarter
Recently, IQVIA released a review of the Chinese hospital medicine market in the first quarter of 2020.
2020-07-21 09:13 -
Remdesivir generic drug is on sale, the price is as low as $53/bottle
In order to alleviate the new crown pneumonia (COVID-19) epidemic, the Drug Administration of India (DCGI) has accelerated the approval of three pharm...
2020-07-20 17:11 -
Chinese firm builds $79M COVID-19 vaccine plant, eyes production next year
On Saturday, China’s AIM Vaccine Group broke ground on a manufacturing and R&D base for its coronavirus vaccine in the city of Ningbo. The company is...
2020-07-20 11:06 -
Yaben Chemical's Shangyu base will produce 'anti-aging drugs'
On July 17, an investor asked Yaben Chemical whether it was true that the company had completed the relevant procedures for nmn.
2020-07-20 11:00
Hot News
- Wanhua Signs 70K HDI Acquisiti... Apr 16, 2025
- Kuwait Petroleum subsidiary ac... Apr 27, 2025
- Global Chemical Supply Chain C... Apr 30, 2025
- BASF Divests Two Joint Venture... Apr 23, 2025
- UK Slashes Tariffs on 89 Produ... Apr 17, 2025
Related Products